Home/Filings/4/0001828153-26-000002
4//SEC Filing

Howze Yalonda 4

Accession 0001828153-26-000002

CIK 0001733294other

Filed

Jan 15, 7:00 PM ET

Accepted

Jan 16, 4:05 PM ET

Size

8.5 KB

Accession

0001828153-26-000002

Insider Transaction Report

Form 4
Period: 2026-01-15
Howze Yalonda
CHIEF LEGAL OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-01-15+3352,680 total
  • Tax Payment

    Common Stock

    2026-01-15$5.64/sh99$5582,581 total
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F2]
    2026-01-153351,673 total
    Common Stock (335 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents the right to receive one share of the company's common stock.
  • [F2]The grant of 53,550 restricted stock units was made on April 5, 2023. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on April 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.
Signature
/s/ Shawna-Gay White, Attorney-in-Fact|2026-01-16

Issuer

Generation Bio Co.

CIK 0001733294

Entity typeother

Related Parties

1
  • filerCIK 0001828153

Filing Metadata

Form type
4
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 4:05 PM ET
Size
8.5 KB